99 related articles for article (PubMed ID: 12538509)
21. [Signal transduction by protein tyrosine kinases and antitumor agents].
Mao YJ; Li HH; Li JF; Shen JS
Yao Xue Xue Bao; 2008 Apr; 43(4):323-34. PubMed ID: 18664191
[TBL] [Abstract][Full Text] [Related]
22. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
23. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy.
Cui X; Schiff R; Arpino G; Osborne CK; Lee AV
J Clin Oncol; 2005 Oct; 23(30):7721-35. PubMed ID: 16234531
[TBL] [Abstract][Full Text] [Related]
24. Tyrosine kinase receptors as attractive targets of cancer therapy.
Bennasroune A; Gardin A; Aunis D; Crémel G; Hubert P
Crit Rev Oncol Hematol; 2004 Apr; 50(1):23-38. PubMed ID: 15094157
[TBL] [Abstract][Full Text] [Related]
25. Inhibitors of protein kinase signaling pathways: emerging therapies for cardiovascular disease.
Force T; Kuida K; Namchuk M; Parang K; Kyriakis JM
Circulation; 2004 Mar; 109(10):1196-205. PubMed ID: 15023894
[TBL] [Abstract][Full Text] [Related]
26. Inhibitors of signaling in myelodysplastic syndrome.
Gore SD
Best Pract Res Clin Haematol; 2004 Dec; 17(4):613-22. PubMed ID: 15494298
[TBL] [Abstract][Full Text] [Related]
27. Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways.
Roy V; Perez EA
Breast Cancer Res Treat; 2009 Jul; 116(1):31-8. PubMed ID: 19101790
[TBL] [Abstract][Full Text] [Related]
28. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
[TBL] [Abstract][Full Text] [Related]
29. Role of tyrosine kinase inhibitors in cancer therapy.
Arora A; Scholar EM
J Pharmacol Exp Ther; 2005 Dec; 315(3):971-9. PubMed ID: 16002463
[TBL] [Abstract][Full Text] [Related]
30. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.
Gollob JA; Wilhelm S; Carter C; Kelley SL
Semin Oncol; 2006 Aug; 33(4):392-406. PubMed ID: 16890795
[TBL] [Abstract][Full Text] [Related]
31. Acquired resistance to small molecule ErbB2 tyrosine kinase inhibitors.
Chen FL; Xia W; Spector NL
Clin Cancer Res; 2008 Nov; 14(21):6730-4. PubMed ID: 18980964
[TBL] [Abstract][Full Text] [Related]
32. Target-based therapies in breast cancer: current status and future perspectives.
Normanno N; Morabito A; De Luca A; Piccirillo MC; Gallo M; Maiello MR; Perrone F
Endocr Relat Cancer; 2009 Sep; 16(3):675-702. PubMed ID: 19525314
[TBL] [Abstract][Full Text] [Related]
33. Targeting epidermal growth factor receptor signaling: early results and future trends in oncology.
Lage A; Crombet T; González G
Ann Med; 2003; 35(5):327-36. PubMed ID: 12952019
[TBL] [Abstract][Full Text] [Related]
34. Signal transduction--directed cancer treatments.
Sausville EA; Elsayed Y; Monga M; Kim G
Annu Rev Pharmacol Toxicol; 2003; 43():199-231. PubMed ID: 12195027
[TBL] [Abstract][Full Text] [Related]
35. GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences.
Shah BH; Catt KJ
Trends Neurosci; 2004 Jan; 27(1):48-53. PubMed ID: 14698610
[No Abstract] [Full Text] [Related]
36. Complexity of receptor tyrosine kinase signal processing.
Volinsky N; Kholodenko BN
Cold Spring Harb Perspect Biol; 2013 Aug; 5(8):a009043. PubMed ID: 23906711
[TBL] [Abstract][Full Text] [Related]
37. Signal transduction pathways.
Kelland L
IDrugs; 1998 Aug; 1(4):394-6. PubMed ID: 18465567
[TBL] [Abstract][Full Text] [Related]
38. Small-molecule inhibitors of signal transduction pathways in leukemia therapeutics: how to assess selectivity for malignant signals.
White MK
Leukemia; 2003 Sep; 17(9):1759-61. PubMed ID: 12970775
[No Abstract] [Full Text] [Related]
39. Mechanism of action of erbB tyrosine kinase inhibitors.
Fry DW
Exp Cell Res; 2003 Mar; 284(1):131-9. PubMed ID: 12648472
[TBL] [Abstract][Full Text] [Related]
40. [Progress in research on focal adhesion kinase signal transduction and cross-talk].
Bian Q; Wang YJ; Shi Q
Zhong Xi Yi Jie He Xue Bao; 2005 Nov; 3(6):495-7. PubMed ID: 16282067
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
